Background: Sepsis is the leading
cause of death for newborns and young children. It's critical to identify
patients who have a high risk of dying and to correctly predict outcomes early
on. In children with sepsis, the platelet-lymphocyte ratio (PLR), a recently
developed inflammatory test, indicates a more severe inflammatory response and
is a risk factor for mortality.
Objective: The aim of this study is to
prove the value of high PLR as a risk
factor for pediatric sepsis mortality.
Methodology: This study used an
observational analytic research design (retrospective study) with a
case-control design conducted at Prof. I G. N. G. Ngoerah
General Hospital, Denpasar. The data were collected from medical records of 148 patient with sepsis
or shock sepsis admitted in Emergency Room and Pediatric Intensive Care Unit from
December 2021 to May 2023. Samples were taken consecutively divided into non
survivors and survivors outcome. PLR was calculated as: Platelet count/
Lymphocyte count.
Result: A
total of 148 pediatric patients with age range was 1 month–18 years old with a
median (IQR) age of 53 month in non-survivor group. The median (IQR) values of
PLR in non-survivor groups were 178,3 (292) respectively. Higher PLR values
were more common in non-survivors group (60,8%). High PLR value as a risk
factor for childhood sepsis mortality (OR 3,67; CI 95% 1,85-7,26;
p=0,001).
Conclusion: High PLR value as risk
factor for pediatric sepsis mortality.
Keywords: Platelet to lymphocyte Ratio,
Pediatric sepsis, mortality
INTRODUCTION
Sepsis
as on organ dysfunction, is a life-threatening condition brought on by
immunological dysregulation in response to an infection. It is the leading cause of death for
new-borns and young children globally, particularly in lower-middle-income nations.1,2
Accurately predicting the course of events and identifying patients at high
risk of mortality are critical in the early stages so that the patient receives
appropriate, life-saving care.3
One in five deaths overall occurs as a
result of sepsis, with the majority occurring in new-borns and children.4
Regarding its classification, sepsis is a potentially deadly illness with
mortality rate that affects approximately 10% of individuals with sepsis and
septic shock. Depending on how many organs are malfunctioning, the death rate
in children with at least one comorbid condition will rise and eventually reach
76%. The prevalence of severe sepsis in South Korea treated in the Pediatric
Intensive Care Unit is approximately 7.3% with a mortality rate of 64.6%. In
2002, 32% of children in developing countries were treated in intensive care
with a diagnosis of sepsis and septic shock with a mortality rate of 57.3%.4
In Indonesia data from Doctor Sutomo
Hospital found 27.08% with severe sepsis
were, 14.58% sepsis, and 58,33% sepsis. Sepsis incidence in PICU at Cipto
Mangunkusumo Hospital was 19.3% of 502 pediatric septic shock with mortality
rate of 54%.5 Meanwhile, according to the Riskesdas 2007, neonatal
sepsis has a high mortality rate of 20.5%. The prevalence of sepsis aged 0-18
years at Sanglah Hospital Denpasar in 2018 was dominated by the infant age
category (<2 years) at 57% with septic shock is the most common diagnosis.4
Sepsis is not only a medical issue but also a global socioeconomic one because
it significantly quality of life and increases death rates. Therefore, a
precise sepsis prognosis is crucial.
The prognosis of sepsis in children has
been assessed using a number of predictors and grading methods, including the
PELOD-2 score. However, this necessitates particular tests that establishments
with inadequate equipment are unable to carry out.1 Some other
parameters used to predict sepsis mortality are procalcitonin, ferritin, and
lactate, but this examination requires quite a long time result, expensive,
most not available in rural area. In recent years, the number of platelets and
lymphocytes is known to play an important role in the inflammatory process in
sepsis.6 The Platelet to Lymphocyte Ratio has drawn interest as a
possible marker of inflammation in a number of illnesses, including sepsis.7
Research has demonstrated that PLR can be used to identify infants at risk for
early sepsis. A high PLR as sepsis mortality risk factor which can
be done easily, has a fast turnaround time, can be accessed in areas with
limited facilities, and is obtained at a low cost from routine blood tests.8
Although PLR has
been frequently used
in diagnosis and
prognosis of sepsis
in neonates and
adults, It has not been studied much in the pediatric population. Some studies
have shown non-significant results
when using PLR
as a predictor
for sepsis outcomes.8
Based on several problems described above,
it is highly recommended that this examination can provide early information
regarding childhood sepsis mortality. This study aims to assess PLR as a risk
factor for sepsis mortality in pediatric patients treated in the PICU
(Pediatric Intensive Care Unit) and Emergency Unit. This research is expected
to improve understanding and outcomes in sepsis patients. Our findings can
provide a basis for future research and hopefully reduce the mortality and
morbidity rates of sepsis in children.
METHOD
This
research is an observational analytical research design (retrospective study)
with a case-control design. Dependent variable is sepsis mortality divided to
non-survivor group and survivor group taken through medical records. Independent
variable is PLR taken from medical record. Confounding variable control by
design include malignancy, congenital heart disease, Immunodeficiency, chronic
kidney disease. Confounding variable control by analysis is age, gender and
nutritional status.
Target population was all pediatric patients with
sepsis and septic shock diagnosed by supervisor in charged collected from
medical record. The accessible population in this study was pediatric patients
aged 1 month – 18 years with a diagnosis of sepsis and septic shock under
treatment at the Children's Emergency Room and Pediatric Intensive Care Unit
(PICU) at Prof. Dr. I G.N.G. Ngoerah Hospital taken from medical record.
Inclusion criteria were sepsis and shock sepsis pediatric patients aged 1 month
– 18 years and complete subject data in the register. Exclusion criteria is malignant
disease, congenital heart disease, chronic kidney disease, children with
HIV/AIDS.
The research subjects were taken using consecutive
sampling until the number of subjects was fulfilled. The sample size was
calculated using a formula two proportion independent with effect size 0,24 was
used and with minimum sample size is 148 subjects.9 Some variable in
this study included: age, gender, nutritional status, PLR, PELOD-2, organ
dysfunction, patient referral, sepsis outcome. The operational definition of
variables is as follows:
1. Age
presented on a categorical scale by toddler (1-59 month), child (60 -119 month),
and teenager (120-216 month).
2. Gender
is obtained through patient medical record data. Data is divided into male and female
and presented on a nominal data scale.
3. Nutritional
status presented in categorical scale divided into well Nourished (Z-score ≥
-2.0 to Z-score ≤ 2.0), wasted (Z-score < -2SD) and overweight (Z-score >
2SD).
4. Platelet
to Lymphocyte Ratio is ratio of platelet count divided lymphocytes count obtained
from medical record take on day-1, 4 or 7 after diagnosed with sepsis or septic
shock. The higest PLR value taken from those day. Cut off point that used in
this study is 157, based on study result in Prof. Dr. R. D. Kandou Central
General Hospital. The PLR value increases if PLR ≥ 157 and normal if < 157 with a nominal data scale.10
5. Sepis
or shock sepsis mortality diagnosed by the doctor in charge taken from medial
ercord. Mortality sepsis is divided into case (non-survivor) and control (survivor
group). Non survivor group is sepsis/shock sepsis child who died within 28 days
during hospitalized. Survivor is sepsis/shock sepsis child who survived within
28 days of hospitalization. Data is presented on a nominal data scale.
6. PELOD-2
presented on a numerical scale, and then presented on a categorical data scale
PELOD-2 ³ 7
and PELOD-< 7.
7. Organ
dysfunction occurs as a result of sepsis conditions such as failure in the
brain, heart, lungs, kidneys, gastrointestinal and microcirculation. Variables
are presented on a categorical scale, namely 1 organ, 2 organs and > 2
organs.
8. Referral
patients are patients referred by general practitioners or specialist doctors
or other health facilities to diagnose or receive further treatment. Variables
are presented on a nominal data scale.
9. Malignancy
characterized by the growth and spread of abnormal cells in the body like blood
cell malignancies (leukaemia) and solid tumors.
10. Congenital
heart disease is condition of heart problems in children who have had
abnormalities or problems with the structure of their heart since birth.
11. Chronic
kidney disease is damage to kidney tissue or a decrease in the glomerular
filtration rate (GFR) of less than 60 mL/min/1.73 m2 for 3 months or more with
or without kidney damage.
Research Procedure
This research uses secondary data in the
form of patient medical record. Cases that meet the inclusion criteria included
as research subjects using consecutive sampling until the sample size is
reached. Data collection was carried out by recording characteristic data,
clinical data, and what was needed in the research. The collected data is then analysed
using a computer program.
Statistical analysis
Descriptive analysis of numerical data,
normality of data distribution is determined by carrying out the
Kolmogorov-Smirnov test (if p > 0.05). If numerical data with a normal
distribution is presented in the form of mean and SD, while numerical data with
a non-normal distribution is presented in the form of median and interquartile
range (IQR). Numerical data with a normal distribution is carried out by the t
test and if the data is not normally distributed then the Mann-Whitney test is
carried out.
Bivariate
test of the independent variable on a categorical scale with the dependent
variable on a categorical scale uses a logistic regression test to obtain the
Odds Ratio value. Multivariate analysis is carried out by controlling
confounding variables if these variables are significantly related to the
dependent variable. The level of significance used is if the P value is
<0.05.
RESULT
This research was carried out at RSUP
Prof. Dr. I G.N.G. Ngoerah from December 2021 to May 2023. The research flow
diagram presented in Figure 1 shows 177 patients with septic
shock/sepsis that treated in the PICU
and pediatric emergency room. Total 148 subjects who met the inclusion and
exclusion criteria were then studied.
Based on Table 1, the median age in
the case group is 53 months and the control group is 22 months with a range of
1-215 months. Nutritional status was divided into 3 categories wasted,
well-nourished and overweight, with the majority in the case group being wasted
(73.3%) than in the control group (37.8%). Overweight found 8.1% and in the
control group 6.3%. Median (IQR) PELOD-2 in the case group 11.5 (6.2) and 6.0
(6.3) in the control group. Most organ dysfunction was found with more than 2
organs in the case group 74.0% and in the control group with 2 organ
dysfunction is 58.1% and 29.7% in the control. The number of referrals in the
case group 59.5%, higher than in the control group (54.1%). The median (IQR) of PLRvalue was
178.3 (292) in the case group and 64.4 (151.1) in the control group.
In Table 2, male 58,1% in the case group, higher
than in the control group (52.7%). Female in the case group was 41.9%, lower
than in the control group (47.3%). There was no difference in gender proportion
between the case and control groups and the value was not statistically
significant (OR 1.24; 95% CI 0.65-2.38; p=0.508). Based on age, toddler in the
case group 52.7% and in the control group is 74.3%. Child in case group found
17,6%, higher than in controlled group 9,5%. Teenager in case group is higher
31,1% than in controlled group 16,2%. Age is associated death in childhood
sepsis (p=0.015).
Nutritional status is divided into wasted, well-nourished and overweight. Wasted condition in the case group is 73.3% and higher than the control group 37.8%. There was a difference in the proportion of wasted in the case group which was significantly higher than the control group with an OR of 6.0. Wasted is a risk factor for pediatric sepsis mortality (OR 6.0; 95% CI 2.79-13.10; p=0.001). Subjects with overweight status were 8.1% in the case group and 8.2% in the control group. There were no differences in proportions between the case and control groups (OR 0.32; 95% CI 0.08-1.18; p=0.08).
Pediatric logistic organ dysfunction-2 (PELOD-2) ³7, 86,5% in the case group, higher than
the control group 41.9%. There was a difference in the proportion of PELOD-2 ≥7
in the case group which was significantly higher than the control group with an
OR of 8.88. PELOD-2 ≥7 is a risk factor for pediatric sepsis mortality (OR
8.88; CI95% 3.95-19.97; p=0.001). The number of referrals in the case group was
higher (59.5%), compared to the control group (54.1%). However, there was no
statistically significant difference (OR 1.25; 95% CI 0.65-2.39; p=0.507).
Based on Table 2, in the case group found 60.8%
had high PLR values. In the control group, 29.7% had a high PLR. There was a
significant difference in the proportion of PLR in the case group compared to
the control group with an OR of 3.67. High PLR is a risk factor for pediatric
sepsis mortality (OR 3.67; 95% CI 1.85-7.26; p=0.001).
Multivariate analysis with logistic regression was carried out on all variables and obtained high PLR values (aOR 5,6; 95%CI 2,12-14,78; p=0.001) and wasted status (aOR 5,85; 95% CI 2,54-13,43; p=0.001) which is an independent factor of several variables studied which are associated with childhood sepsis mortality. PELOD-2 >7 as risk factor of child sepsis mortality (aOR 11,6; 95% CI 4,13-32,61; p=0.001). Based on multiple logistic regression analysis, the PLR value as a risk factor for pediatric sepsis mortality after controlling for confounding variables, the result presented in Table 3.
DISCUSSION
Sepsis
is a life-threatening condition with the death rate increasing every year.4
From all patients treated in the PICU and emergency room, it was found that 36%
were patients with sepsis and septic shock, higher than data from previous
research at the same location in 2019, namely 35.7%. RSUP Prof. Dr. I G.N.G.
Ngoerah is a type A hospital belonging to the Ministry of Health located in
Bali. As a referral hospital for Bali and Nusa Tenggara, this causes a high
number of patients diagnosed with sepsis and septic shock who are treated at
this hospital.
This research was conducted on data from medical
record with 177 patients who were treated with a diagnosis of sepsis/septic
shock in the PICU and pediatric emergency room at Prof. Hospital. Dr. I G.N.G.
Ngoerah in August 2021- October 2023 (Figure 1). The results of this study
showed that the male gender who died (58.1%) was higher than those who lived (52,7%).
Female gender in the case group was 41.9% lower than in the control group
47.3%. In this study, there was no difference between male or female gender as
a risk factor for sepsis mortality, but it was found that the number of male in
the sepsis group who died was higher than in the sepsis group who survived.
Research by Botan et al., conducted in the PICU for 5 years, obtained the same
result that from 2,781 children, 53.4% of the children who died were male. Accordance
with a study of 1919 pediatric patients in PICU for 6 years with the result
that 60.5% of children who died were male.11 Male more often
experience more severe conditions due to increased pro-inflammatory mediators
such as TNF, IL-6, IL-10 causing dysfunction and even organ failure which
causes a high risk of death. While female sex hormones naturally guard against
inflammation, male sex hormones depress the immune system.10,12
Age is classified according to minister of health of
the republic of Indonesia, presented as toddler
(1-59 month), child (60 -119 month), and teenager (120-216 month). Median (IQR)
was 53 months (125.5). Research conducted at RSUP Prof. IG.N.G. Ngoerah in 2018
received a median (IQR) of 10.5 months (6.48).4 At the Prof. R.D.
Kandou Hospital in Manado, North Sulawesi, another study with a similar outcome
was carried out from February to August 2020. The mean age of the survivors was
50 months, while the mean age of the deceased was 59.62 months.10
In this study, toddler died in the sepsis group 52.7% and 74.3% survived in the sepsis group. In
child group 17,6% case in non-survivor group higher than in survivor group
about 9,5%. In teenager group there 31,1% higher than in survivor group 16,2%. We
found a relationship between age and sepsis mortality in children with a P
value <0.05 (p=0.015). These results are in accordance with the Southeast
Asia Infectious Disease Clinical Research Network study which reported that the
toddler age group was the group most frequently diagnosed with septic shock. Reasearch
in Turkey with a total of 2,781 critically ill children in the PICU found an
average age of 64 months or less than 6 months.11 Hermon et al.'s
research, conducted in PICU for 10 years, stated that the incidence of sepsis
in children less than 6 years old was more than 70%.13 In this study
found, child and teenager group with higher mortality in sepsis than in toddler
group. This condition can caused by malnutrition happened most case in child
and teenager group that caused higher risk of mortality in those patient. That
could be caused the primary diagnosed more severe in child and teenager group
that caused PELOD-2 score higher and more disfunction organ can happened that
increased of mortality case.
Nutritional status was divided into 3 categories wasted,
well-nourished and overweight with the majority in the case group being
73.3% is wasted. The wasted status in
the case group (73.3%) was found to be higher than the control group (37.8%).
There was a difference in the proportion of wasted in the case group which was
significantly higher than the control group with an OR of 6.0. Wasted is a risk
factor for pediatric sepsis mortality (OR 6.0; 95% CI 2.79-13.10; p=0.001).
Subjects with overweight status 8.1% in the case group and 8.2% in the control group. There was no
difference in proportions in the case and control groups (OR 0.32; 95% CI
0.08-1.18; p=0.08). This condition is in accordance with research found that
51.7% of critically ill patients experienced malnutrition with the risk factor
for poor nutritional status on sepsis mortality was 3.06 times after controlled
all confounding facto. Nutritional disorders that occur in patients are caused
by changes in anabolism and catabolism status.14 These results are
in accordance with research conducted by Irving et al. based on an analysis of
417 patients aged less than 18 years treated with severe sepsis in 128 PICUs
throughout the world, where based on BMI the majority, 67%, were classified as
wasted or overweight.15
Malnutrition with care in the PICU room is associated
with increased mortality rates, length of stay, longer use of ventilators and
increased risk of infection during care. The stress response to critical
illness is characterized by protein breakdown, providing free amino acids in
the anti-inflammatory process and tissue repair. The inflammatory response to
infection releases inflammatory mediators by reducing appetite, increasing
skeletal catabolism and inhibiting the body's ability to store energy. Protein
loss in severe and long-term illnesses will have a negative impact on lean body
mass. Infants and children with minimal fat reserves are very susceptible to
the adverse effects of this phenomenon.16
In this study, the median (IQR) PELOD-2 in the case
group was 11.5 (6.2) and in the control group 6.0 (6.3). Then, if it is
categorized into high and low PELOD-2 values with a cut-off value of 7, it is obtained
that PELOD-2 ≥7 in the sepsis group died higher (86.5%)
than the control group (41.9%). There was a difference in the proportion of
PELOD-2 ≥7 in the case group significantly higher
than the control group with an OR of 8.88. PELOD-2 ≥7 is a risk factor for mortality
in pediatric sepsis (OR 8.88; CI95% 3.95-19.97; p=0.001). Accordance with
research conducted in the PICU in Cipto Mangunkusumo Hospital with subjects who
survived had an average PELOD-2 score of 7.59 ± 3.025, while those who died had
an average score of 13.9 ± 4.564.17 Study at Dr. Mohammad Hoesin
Palembang showed that the PELOD-2 score was significantly different in PICU
patients who managed to improve and patients who died. Mean in survivor group
with PELOD-2 score of 2.58 ± 1.41, while patients who died is 10.23 ± 4.53.18
The research at Dr. Moewardi Surakarta obtained a PELOD-2 score >20 with a
7.75 times greater risk of mortality compared to patients with a PELOD-2 score
<20. A PELOD score of 20 has a probability of death of around 50%, and the
higher the PELOD score, the higher the probability of death in a child
(sensitivity 54.5%; specificity 80.9%; p < 0.5).19 Another study
evaluated PELOD-2 scores based on median values and interquartile ranges. It was found
that PICU patients who successfully experienced improvement had a median
PELOD-2 score of 5 (3-6.25), while patients who died during treatment had a
median PELOD-2 score of 9 (6-13).20
A tool used to assess the severity of organ dysfunction in children in
critical condition is the PELOD-2 score. Subjects
with organ dysfunction were divided into dysfunction in 1 organ, 2 organs, and
more than 2 organs. Organ dysfunction was most commonly found with more than 2
organs in the deceased sepsis group (74.0%) compared to the living sepsis group
with 2 organ dysfunction (58.1%). In the case group, the number of organ
dysfunction was >2, which was the largest number of cases, namely 68 (77.3%)
and in the control group, the majority had dysfunction of 2 organs with 52
cases (63.1%). Organ dysfunction is a risk factor for death in childhood sepsis
(p=0.001). Accordance with research conducted by Wati et al., with the highest
number of patients dying based on organ involvement, which was found to be the
majority with involvement of 3 organs at 58.3%.4 The number of
referral cases in the dead sepsis group was higher, namely 59.5%, compared to
the live sepsis group, namely 54.1. However, no risk factors were found for
referral cases to increase sepsis mortality in children (OR 1.25; 95% CI
0.65-2, 39; p=0.507).
In this study, it was found that a high PLR was an
independent risk factor for pediatric sepsis mortality. The median (IQR) value
of PLR was 178.3 (292) in non-survivor (case) group. This result found higher
than cut off point that used in this study is 157 that devided case and
controlled group taken from study result in Prof. Dr. R. D. Kandou Central
General Hospital. The total of high PLR in this study found 45%. This is higher than effect size that
used in this study 24%.9 In non-survivor group was found to be 60.8%
with a high PLR value. In survivor group was found to be 29.7% with a high PLR
value. There was a significant difference in the proportion of PLR in the non-survivor
group compared to survivor group with an OR of 3.67. A high PLR value is a risk
factor for pediatric sepsis mortality (OR 3.67; 95% CI 1.85-7.26; p=0.001). In
the multivariate analysis, it was found that high PLR was an independent
variable as a risk factor pediatric sepsis mortality after controlling
confounding variables analytically (aOR 5,6; 95% CI 2.12-14,78; p=0.001). Apart
from these risk factors, this research also found that characteristics such wasted
as risk factors for pediatric sepsis motility (aOR 5,85; 95% CI 2,54-13,43;
p=0.001) and PELOD-2 >7 as risk factors for pediatric sepsis motility (aOR
11,6; 95% CI 4,13-32,615; p=0.001)
This result in line with meta-analysis study consist
of 16 studies comprising 2403 septic patients which found that PLR levels were
significantly higher in no survivors than in survivors. This findings support
PLR to be a promising biomarker in
prediction and prevention of sepsis mortality.21 We also
discovered that the PICU at Prof. Dr. R. D. Kandou Central General Hospital in
Manado had similar results, with increased PLR in non-survivor group. The same outcomes were shown in study, where the mean
PLR for those who survived sepsis was 77.53 and 157.2 in non- survivor group.
This suggests a substantial correlation between PLR and death.11 In adults, a study showed that the PLR in adult
sepsis patients who
survived was 111 and 209 in non-survivor
group.22 Study in adult
patients with total 5537 sepsis patient using SOFA score calculated
within 24 hours of ICU admission, showed that a high PLR value >200 was
significantly related to mortality.6
A condition known as sepsis is characterized by an
uncontrollably high level of systemic inflammation, which is then followed by
inflammatory mediator-induced increased vascular permeability and plasma
protein leakage. These events have the potential to cause hypotension, shock,
multiorgan dysfunction syndrome (MODS), and even death.22 During
inflammation, platelets and neutrophils interact, causing responses on the
surface of the endothelium.23 Chemotaxis is the process by which
platelets actively stimulate neutrophils and monocytes to move to the site of
tissue damage. Moreover, platelets
indirectly stimulate the contact between monocytes and neutrophils by a number
of methods, such as by activating TREM-1 in neutrophils, which in turn triggers
a variety of pro-inflammatory reactions.24 By producing lymphocyte
apoptotic products, lymphocytes can stimulate anti-inflammatory responses. The immune system is weakened by an
overabundance of apoptotic lymphocytes in sepsis, which typically results in
septic shock, immunological paralysis, and eventually death.25
The haemostatic system is impaired in sepsis, and platelets are
essential for haemostasis as well as the immune system's reaction to various
assaults. Following pathogen invasion, the body's coagulation system is
triggered at the infection site, and local capillaries create thrombus as a
defensive measure to keep the infection contained to the lesions. These
localized reactions spread throughout the body during sepsis, and disseminated
intravascular coagulation (DIC) and MODS are the results of an uncontrolled
"inflammation-coagulation" process.26 Patients with high
platelet counts experience more substantial inflammation as a result of the
thromboxane’s and other mediators secreted by platelets.27
Apoptosis-induced lymphopenia is frequent during
sepsis, and its duration and intensity are related to worse clinical outcomes,
including increased mortality rates and prior infections. One of the most
plausible causes of injury-related lymphopenia is apoptosis, which also
contributes both directly and indirectly to injury-induced immunoparalysis.
Because active cells travel to inflammatory sites, lymphocyte apoptosis
increases, resulting in a decrease in lymphocyte count that can last for up to
28 days.28 Significant inflammation is indicated by a high platelet
count, whereas a low lymphocyte count points to a poor immune response to
infection. Increased platelet to lymphocyte ratio and low lymphocyte counts
were the results of this disorder. Consequently, elevated PLR levels have been
associated to significant systemic inflammation and have the potential to
exacerbate sepsis and other illnesses.6
In children, PLR studies have been limited to an
overall critical patient condition. A high PLR value implies a more severe
inflammatory response. Clinical worsening, a worse prognosis, and mortality
could result from more severe inflammation. Our study indicated that
PLR levels among sepsis non-survivors are significantly higher than the
survivors and high PLR value as risk factor of pediatric sepsis mortality.
Therefore, PLR is a low-cost, easily perform and straightforward potential
clinical predictor that can be used in regions with limited facilities
settings.
Platelet Lymphocyte Ratio research in children has
been restricted to a general critical patient state. A higher degree of
inflammation is implied by a higher PLR value. More severe inflammation may
lead to worsening clinical symptoms, a worse prognosis, and mortality.
According to our research, PLR levels are considerably higher in non-survivors
of sepsis than in survivors, and a high PLR value is associated with a higher
risk of pediatric sepsis mortality. Therefore PLR is simple, low cost, routine
examination that can used in limited facilities.
This study has weaknesses, including this study did
not examine other factors that might influence sepsis mortality in pediatric.
Wasted as another factor influencing childhood sepsis mortality needs to be
studied further to prove a significant relationship.
CONCLUSSION
Platelet
Lymphocyte Ratio as risk factor pediatric sepsis mortality. High PLR increased
risk of mortality 5,6 times compared with normal PLR value. Therefore, a high
PLR is a risk factor for determining pediatric sepsis mortality with low cost,
fast results, and is easy to perform so it can be used in areas with limited
facilities. Apart from these risk factors, this research also found that
characteristics such nutritional status (wasted) were significant risk factors
for sepsis motility.
REFERENCES
1.
Hadinegoro
SR, Chairulfatah A,
Latief A, Pudjiadi
AH, Malisie RF, Alam A. Konsensus
diagnosis dan tata laksana sepsis pada anak. 1st ed. Jakarta: IDAI. 2016:1-47
2.
Fuchs, J. Bielicki, S. Mathur, M. Sharland, J.N. Van
Den Anker. Reviewing the WHO guidelines for antibiotic use for sepsis in
neonates and children. Paediatr Int Child Health. 2018;38:S3-15.
3.
Vincent
JL, Pereira AJ,
Gleeson J, De
Backer D. Early
management of sepsis.
Clin Exp Emerg
Med. 2014;1:3-7.
4.
Wati, Dyah Kanya, dkk., Profil Sepsis Anak di
Pediatric Intensive Care Unit Rumah Sakit Umum Pusat Sanglah Denpasar–Bali.
Sari Pediatri. 2019;2:152-8.
5.
Priyatiningsih DR. Karakteristik sepsis di pediatric
intensive care unit RSUPN dr. Cipto Mangunkusumo. [dissertation]. [Jakarta]:
Fakultas Kedokteran Universitas Indonesia; 2016.
6.
Shen Y, Huang
X, Zhang W.
Platelet-to-lymphocyte ratio as a prognostic predictor of mortality for
sepsis: interaction effect with disease severity-a retrospective study. BMJ
Open. 2019;9:e022896.
7.
Can E, Hamilcikan
S, Can C.
The value of
neutrophil to lymphocyte ratio and platelet to lymphocyte
ratio for detecting early-onset
neonatal sepsis. J
Pediatr Hematol Oncol.
2018;40:e229-32.
8.
Bharadwaj
N, Singh HB,
Anjum S, Tadury
A. Does the
platelet to neutrophil ratio and platelet to lymphocyte ratio predict
newborn sepsis? a case control study. Paripex Indian J Res. 2018;7:192-3.
9.
Zhao C., Wei Y., Chen D., Jin J.,
Chen H. Prognostic value of an inflammatory biomarker-based clinical algorithm
in septic patients in the emergency department: an observational study. International
Immunopharmacology . 2020;80:p. 106145.
10. Kurniawan F, Jeanette I, Manoppo C, Runtunuwu
AL, Lolombulan JH, Rampengan NH. Platelet-limphocyte ratio and sepsis outcome
in children. Paeditrica Indonesiana.2021;61:322-7.
11. Botan E, Gün E, Şden EK, Yöndem C,
Gurbanov A, Balaban B, Kahveci F, Özen H, Uçmak H, Gençay AG, Kendirli T.
Characteristics and timing of mortality in children dying in pediatric
intensive care: a 5-year experience. Acute Crit Care. 2022 Nov;37(4):644-653.
12. Angele MK, Pratschke S, Hubbard WJ,
Chaudry IH. Gender differences in sepsis. Virulence. 2014;5:12-9.
13. Hermon MM, Etmayr T, Brandt JB, Sadeghi K,
Burda G, Golej J. Pediatric infection and sepsis in five age subgroups:
single-center registry. Wien Med Wochenschr. 2021 Feb;171(1-2):29-35.
14. Gao Q, Cheng Y, Li Z, Tang Q, Qiu R, Cai
S, Xu X, Peng J, Xie H. Association Between Nutritional Risk Screening Score
and Prognosis of Patients with Sepsis. Infect Drug Resist. 2021 Sep
17;14:3817-3825.
15. Irving SY, Daly B, Verger J, Typpo KV,
Brown AM, Hanlon A, Weiss SL, Fitzgerald JC, Nadkarni VM, Thomas NJ, Srinivasan
V; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and
Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. The
Association of Nutrition Status Expressed as Body Mass Index z Score With
Outcomes in Children With Severe Sepsis: A Secondary Analysis From the Sepsis
Prevalence, Outcomes, and Therapies (SPROUT) Study. Crit Care Med. 2018
Nov;46(11):e1029-e1039.
16. Albadi MS, Bookari K. Is Undernutrition
Associated With Deterioration of Outcomes in the Pediatric Intensive Care Unit
(PICU): Systematic and Meta-Analysis Review. Front Pediatr. 2022 May
4;10:769401.
17. Suari, N. M. R., Latief, A., &
Pudjiadi, A. H. (2021). New pelod-2 cut-off score for predicting death in
children with sepsis. Paediatrica Indonesiana(Paediatrica Indonesiana), 61(1),
39-45.
18. Surya R, Saksono S. Logistic Organ
Dysfunction 2 Scoring System in Predicting the Prognosis of Death in Pediatric
Patients with Clinical Sepsis. Journal of Surgery. 2019;2(2):1–12.
19. Hendra, Lukas Runtunuwu A, Irene Chistie
Manoppo J. Pediatric Logistic Organ Dysfunction (PELOD) Score as prognosis of
multiple organ failure in sepsis. Paediatr Indones. 2010;50(4):226–32.
20. Melda M, Triasih R, Nurnaningsih.
Modifying the pelod-2 score to predict mortality in critically ill patients.
Paediatrica Indonesiana(Paediatrica Indonesiana). 2021;61(2):61–8.
21. Wang G, Mivefroshan A, Yaghoobpoor S,
Khanzadeh S, Siri G, Rahmani F, Aleseidi S. Prognostic Value of Platelet to
Lymphocyte Ratio in Sepsis: A Systematic Review and Meta-analysis. Biomed Res
Int. 2022:9056363.
22. Karagoz
I, Yoldas H.
Platelet to lymphocyte
ratio and neutrophil
to lymphocyte ratios
as strong predictors
of mortality in intensive care
population. Rev Assoc Med Bras. 2019.65:633-6.
23. Tayeh
O, Taema KM,
Eldesouky MI, Omara
AA. Urinary albumin/creatinine ratio as an early
predictor of the outcome in
critically-ill septic patients.
Egypt J Crit
Care Med. 2016;4:47-55.
24. Page C, Pitchford S. Neutrophil and
platelet complexes and their relevance to
neutrophil recruitment and
activation. Int Immunopharmacol. 2013;17:1176-84.
25. Thapa S, Prasad PN, Shakya YM. Serum
lactate-albumin ratio as predictor of mortality in severe sepsis and septic
shock at Tribhuwan University Teaching Hospital, Kathmandu. BJHS.
2017;2:191-5.
26. Djordjevic D., Rondovic G., Surbatovic M.,
et al. Neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio,
platelet-to- lymphocyte ratio, and mean platelet volume-to-platelet count ratio
as biomarkers in critically ill and injured patients: which ratio to choose to
predict outcome and nature of bacteremia? Mediators of Inflammation .
2018;2018:15.
27. Balta S., Demırkol S., Kucuk U. The
platelet lymphocyte ratio may be useful inflammatory indicator in clinical
practice. In Hemodialysis International. International Symposium on Home
Hemodialysis . 2013;17(4):668–9.
28. Girardot T., Rimmelé T., Venet F.,
Monneret G. Apoptosis-induced lymphopenia in sepsis and other severe injuries.
Apoptosis. 2017;22(2):295–305.